Codexis (CDXS) Return on Capital Employed (2011 - 2026)
Codexis' (CDXS) quarterly Return on Capital Employed came in at 23.68% in Q1 2026, up 3318.0% year-on-year from 0.69% in Q1 2025, and up 37.28% quarter-over-quarter from 37.75% in Q4 2025.
Codexis (CDXS) Return on Capital Employed (2011 - 2026) Analysis & Trends
Codexis' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 23.68% for Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 3318.0% year-over-year to 23.68% in Q1 2026; TTM through Mar 2026 was 23.68%, a 3318.0% increase from a year earlier, with the FY2025 full-year figure at 33.91%, up 1521.0% from the prior year.
- Return on Capital Employed climbed to 23.68% in Q1 2026 per CDXS's latest filing, from 37.75% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 9.78% in Q2 2022 and bottomed at 62.06% in Q4 2023.
- The 5-year median for Return on Capital Employed is 46.83% (2024), against an average of 38.68%.
- Across the five-year window, Return on Capital Employed sank 4406 bps in 2023 and surged 3318 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 18.0% in 2022, then sank by 245 bps to 62.06% in 2023, then gained by 25 bps to 46.83% in 2024, then climbed by 19 bps to 37.75% in 2025, then surged by 37 bps to 23.68% in 2026.
- Per Business Quant, the three latest CDXS Return on Capital Employed figures stand at 23.68% (Q1 2026), 37.75% (Q4 2025), and 52.95% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | -23.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.68% |
| Dec 31, 2025 | -37.75% |
| Sep 30, 2025 | -52.95% |
| Jun 30, 2025 | -48.38% |
| Mar 31, 2025 | -56.85% |
| Dec 31, 2024 | -46.83% |
| Sep 30, 2024 | -48.49% |
| Jun 30, 2024 | -60.23% |
| Mar 31, 2024 | -49.39% |
| Dec 31, 2023 | -62.06% |
| Sep 30, 2023 | -57.39% |
| Jun 30, 2023 | -34.06% |
| Mar 31, 2023 | -25.60% |
| Dec 31, 2022 | -18.00% |
| Sep 30, 2022 | -15.75% |
| Jun 30, 2022 | -9.78% |
| Mar 31, 2022 | -10.38% |
| Dec 31, 2021 | -11.15% |
| Sep 30, 2021 | -8.71% |
| Jun 30, 2021 | -12.56% |